Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Dividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Repurchased
Growth Metrics
Income Statement
Others
Ratios

Pharma-Bio Serv (PBSV) Gains from Investment Securities (2016 - 2025)

Pharma-Bio Serv's Gains from Investment Securities history spans 14 years, with the latest figure at -$528746.0 for Q4 2025.

  • For Q4 2025, Gains from Investment Securities rose 20.04% year-over-year to -$528746.0; the TTM value through Oct 2025 reached -$661224.0, down 1172.66%, while the annual FY2025 figure was $1.0 million, 1066.67% up from the prior year.
  • Gains from Investment Securities reached -$528746.0 in Q4 2025 per PBSV's latest filing, down from $528746.0 in the prior quarter.
  • In the past five years, Gains from Investment Securities ranged from a high of $528746.0 in Q2 2025 to a low of -$661224.0 in Q4 2024.
  • Average Gains from Investment Securities over 5 years is $164168.8, with a median of $384816.5 recorded in 2023.
  • Peak YoY movement for Gains from Investment Securities: soared 1004.61% in 2021, then plummeted 292.58% in 2024.
  • A 5-year view of Gains from Investment Securities shows it stood at $470000.0 in 2021, then rose by 6.38% to $500000.0 in 2022, then tumbled by 31.33% to $343350.0 in 2023, then tumbled by 292.58% to -$661224.0 in 2024, then grew by 20.04% to -$528746.0 in 2025.
  • Per Business Quant, the three most recent readings for PBSV's Gains from Investment Securities are -$528746.0 (Q4 2025), $528746.0 (Q2 2025), and -$661224.0 (Q4 2024).